Cancilico
PrivateLast Round
Seed
Jan 20, 2026
Total Funding Raised
$2.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cancilico is a health technology company that develops AI-based diagnostic software, MyeloAID, to automate and improve the accuracy of blood and bone marrow analysis for hematological cancers.
Sector
Enterprise Software
Verticals
Project Management, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cancilico Comparables
Compare Cancilico with similar companies based on industry and business-model similarity.
Cancilico Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 20, 2026 |
Key People
Founding team and executive leadership
Cancilico Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CFH Management | Seed |
| TGFS Technologiegründerfonds Sachsen | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2026
Grew 31% QoQ from 13 to 17 employees.
- Jul 25, 2026
Grew 45% QoQ from 11 to 16 employees.
Cancilico Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cancilico's valuation, stock price, and market status.
Is Cancilico a public or private company?
Cancilico is a private company.
What is the current stock price of Cancilico?
Cancilico is a private company with no public stock price. No recent secondary market data is available.
How much is Cancilico worth (valuation)?
Valuation information for Cancilico is not publicly available.
Can I buy Cancilico stock?
Cancilico shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cancilico's last funding round?
Cancilico's most recent funding round was Seed on January 20, 2026.
Who are the main investors in Cancilico?
Key investors in Cancilico include High-Tech Gründerfonds.
Will Cancilico IPO soon?
No public IPO plans have been announced for Cancilico.
How can I track Cancilico secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cancilico's secondary market activity and sign up for updates.